Virta Health

Valuation $9B

About Virta Health

Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Headquarters Virta Health, San Francisco
Founded 2014-05-20
Industry Diabetes, Health Care, Medical, Personal Health
Last Funding Type Series E
Valuation 9
Total Funding $373.00 million dollars
IPO Status Private

Financial

Virta Health may be growing as indicated by the expansion of its provider-led weight loss program to adults with a BMI greater than 25, which suggests an increase in the scale of its operations. Additionally, the company has announced a peer-reviewed study proving the effectiveness of its approach as an alternative to GLP-1 drugs for sustained weight loss, which could enhance its reputation and credibility in the healthcare industry. Furthermore, Virta Health has positioned itself as having a solution for GLP-1 deprescription, potentially addressing a growing need in the market for cost-effective alternatives to GLP-1 drugs.

Virta Health has partnered with the Pro Football Retired Players Association (PFRPA) to help retired NFL players improve their health. This collaboration aims to provide retired athletes with access to Virta's clinically-proven treatment for reversing type 2 diabetes and other chronic metabolic diseases.
Funding Rounds 6
Number of Lead Investors 4
Total Funding Amount  $373.00 million dollars
Number of Investors 22

Related Angels

Raymond Tonsing
View profile
Kevin Moore
View profile
Max Levchin
View profile